PMDA drug package insert
硫酸バリウム散99.1%「共成」
PMDA Prescription drug · カイゲンファーマ株式会社 · package insert May 2, 2022
Key facts
| Brand names | 硫酸バリウム散99.1%「共成」 |
|---|---|
| Nonproprietary names | 硫酸バリウム |
| Companies | 製造販売元／カイゲンファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | X線造影剤 |
| Therapeutic category codes | 877212 |
| YJ codes | 7212032B1036 |
| Approval numbers | 22200AMX00726000 |
| Package insert edition | 第1版 |
| Package insert date | May 2, 2022 |
| PMDA document key | 200343_7212032B1036_2 |
| PMDA company code | 200343 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: